Geoffrey Alan Donnan
Overview
Explore the profile of Geoffrey Alan Donnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yassi N, Yogendrakumar V, Churilov L, Meretoja A, Wu T, Campbell B, et al.
Neurology
. 2024 Nov;
103(12):e210104.
PMID: 39586046
Background And Objectives: The antifibrinolytic agent tranexamic acid has been tested in intracerebral hemorrhage trials with overall neutral results. Ongoing contrast extravasation on CT angiography (spot sign) can identify individuals...
2.
Kurunawai C, Chen C, Willcour M, Tan A, Mahadevan J, Waters M, et al.
Front Neurol
. 2024 Jul;
15:1428198.
PMID: 38957351
Background: Patients with a large vessel occlusion require a transfer from a primary stroke centre to access thrombectomy, often over significant distances in regional areas. We sought to optimise stroke...
3.
4.
Sarraj A, Albers G, Mitchell P, Hassan A, Abraham M, Blackburn S, et al.
Neurology
. 2022 Oct;
100(3):e336-e347.
PMID: 36289001
Background And Objectives: The effect of anesthesia choice on endovascular thrombectomy (EVT) outcomes is unclear. Collateral status on perfusion imaging may help identify the optimal anesthesia choice. Methods: In a...
5.
Yogendrakumar V, Churilov L, Mitchell P, Kleinig T, Yassi N, Thijs V, et al.
Neurology
. 2022 Jan;
98(12):e1292-e1301.
PMID: 35017305
Background And Objectives: Detailed study of tenecteplase (TNK) in patients older than 80 years is limited. The objective of our study was to assess the safety and efficacy of TNK...
6.
Dagonnier M, Wilson W, Favaloro J, Rewell S, Lockett L, Sastra S, et al.
PLoS One
. 2018 Nov;
13(11):e0206321.
PMID: 30439964
Stroke evolution is a highly dynamic but variable disease which makes clinical decision making difficult. Biomarker discovery programs intended to aid clinical decision making have however largely ignored the rapidity...
7.
Dagonnier M, Cooke I, Faou P, Sidon T, Dewey H, Donnan G, et al.
Biomark Insights
. 2018 Jan;
12:1177271917749216.
PMID: 29308009
Application of acute therapies such as thrombolysis for ischaemic stroke (IS) is constrained because of diagnostic uncertainty and the dynamic nature of stroke biology. To investigate changes in blood proteins...
8.
Tse T, Yusoff S, Churilov L, Ma H, Davis S, Donnan G, et al.
Top Stroke Rehabil
. 2017 Apr;
24(6):405-414.
PMID: 28438076
Background: There is a relative lack of longitudinal studies investigating stroke-specific outcomes and quality of life (QOL). This study aimed to identify which factors (level of disability, cognitive functioning, depressive...
9.